Rechercher

PythonReactSEOPDF
OpenClaw

admet-prediction

ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery. Keywords: ADMET, PK, toxicity, drug-likeness, DILI, hERG, bioavailability

huifer0 installations selon la source☆ 0 Étoiles du dépôtv1.0.0

Installation

Suivez les instructions du dépôt pour votre agent. Consultez les fichiers et dépendances avant l’installation.

SkillHub CLI

skillhub install huifer/admet-prediction

Examinez la source et la compatibilité, puis suivez les étapes d’installation.

Donnez le lien à votre agent et demandez-lui d’examiner instructions et dépendances avant d’expliquer les étapes.

Voir la source ↗Guides

Instructions

ADMET Prediction Skill

Predict ADMET properties to prioritize compounds for development.

Quick Start

/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames

What's Included

Property Prediction Model
Absorption Caco-2, HIA, Pgp ML/QSAR
Distribution VDss, PPB, BBB ML/QSAR
Metabolism CYP inhibition, clearance ML/QSAR
Excretion Clearance, half-life ML/QSAR
Toxicity hERG, DILI, Ames, mutagenicity ML/QSAR

Output Structure

# ADMET Profile: CHEMBL210 (Osimertinib)

## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |

## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |

## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |

## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |

## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |

## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |

## Recommendations
**Strengt...

Informations sur la source

Source
github
Repository
openclaw/skills
Path
skills/huifer/admet-prediction
Version
1.0.0
Commit
4980dcd6e6d1e44370778e8128df1689af30afc5
Source de classification
rules
Statut
active
Visibilité
public

Ces informations proviennent de l’analyse indexée et peuvent être anciennes. Vérifiez les fichiers actuels.

Contenu extrait

SKILL.md
# ADMET Prediction Skill

Predict ADMET properties to prioritize compounds for development.

## Quick Start

```
/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames
```

## What's Included

| Property | Prediction | Model |
|----------|------------|-------|
| Absorption | Caco-2, HIA, Pgp | ML/QSAR |
| Distribution | VDss, PPB, BBB | ML/QSAR |
| Metabolism | CYP inhibition, clearance | ML/QSAR |
| Excretion | Clearance, half-life | ML/QSAR |
| Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR |

## Output Structure

```markdown
# ADMET Profile: CHEMBL210 (Osimertinib)

## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |

## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |

## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |

## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |

## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |

## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |

## Recommendations
**Strengt...

Skills associés

OpenClaw

1password

daggerkun007

Set up and use 1Password CLI (op). Use when installing the CLI, enabling desktop app integration, signing in (single or multi-account), or reading/injecting/running secrets via op.